Haemonetics to acquire OpSens for $253M

Haemonetics Corporation announced a definitive agreement to acquire all outstanding shares of OpSens, Inc. for CAD $2.90 per share in an all-cash transaction valued at approximately USD $253 million. OpSens provides fiber optic sensor technology for interventional cardiology.

“Haemonetics Corporation and OpSens, Inc. today announced that they have entered into a definitive agreement under which Haemonetics will acquire all outstanding shares of OpSens for CAD $2.90 per share in an all-cash transaction representing a fully diluted equity value of approximately USD $253 mil”haemonetics.gcs-web.com

• 1 source
• haemonetics.gcs-web.comHaemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc. | Haemonetics CorporationOct 10, 2023

Summarized from public sources; check the original articles before acting on it.